The firm continued to pressure Kelsey and the agency to approve the application—until November 1961, when the drug was pulled off the German market because of its association with grave congenital abnormalities. Several thousand newborns in Europe and elsewhere suffered the teratogenic effects of thalidomide. Though the drug was never approved in the USA, the firm distributed Kevadon to over 1,000 physicians there under the guise of investigational use. Over 20,000 Americans received thalidomide in this "study," including 624 pregnant patients, and about 17 known newborns suffered the effects of the drug.[citation needed] COUNT 10
QSN1 How many Americans were given the drug Kevadon? ANS1 Over 20,000 QSN2 When was the drug taken off shelves in Germany? ANS2 November 1961 QSN3 How many newborns were born with issues due to Kevadon? ANS3 about 17 QSN4 How was Kevadon distributed to doctors? ANS4 under the guise of investigational use QSN5 Why was this drug pulled off shelves? ANS5 association with grave congenital abnormalities QSN6 In what year was thalidomide banned in Germany? ANS6 1961 QSN7 What adverse effect was thalidomide associated with? ANS7 congenital abnormalities QSN8 Thalidomide was distributed in the USA by what name? ANS8 Kevadon QSN9 About how many Americans received thalidomide in a supposed study? ANS9 Over 20,000 QSN10 How many newborn American babies were affected by thalidomide? ANS10 17